SpiroSano is a patent pending technology platform focused on radically changing the way healthcare is delivered for patients with chronic respiratory conditions, such as asthma and COPD, while significantly reducing the associated costs. As a clear differentiator, SpiroSano is the only doctor driven, patient focused, device agnostic and disease specific solution available today in the respiratory space.
The company provides an end-to-end infrastructure for physicians to prescribe personalized and condition-specific kits, receive and analyze the resulting data, and manage the condition via alerts, patient engagement, and data-driven treatments. For example, through the SpiroSano platform, a pulmonologist could prescribe a patient to track a personalized set of parameters such as lung capacity, blood oxygenation levels, activity levels and medication usage. The patient records the parameters through the use of devices such as spirometers, pulse oximeters, adherence monitoring solutions and activity trackers. When the patient uses the devices in the kit, the doctor gains access to the patient’s real-time data through SpiroSano's HIPAA-compliant framework, allowing the doctor to monitor and manage the patient’s condition. Ultimately this will improve patient care by fast-tracking the patient’s path to controlled Asthma or managed COPD, and reduce costs via these gained efficiencies.
SpiroSano received a $100,000 Innovatyion Fund in December 2014.
